These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3926071)
1. Incidence of hyperkalaemia induced by indomethacin in a hospital population. Zimran A; Kramer M; Plaskin M; Hershko C Br Med J (Clin Res Ed); 1985 Jul; 291(6488):107-8. PubMed ID: 3926071 [No Abstract] [Full Text] [Related]
3. Incidence of hyperkalaemia induced by indomethacin. de Jong PE Br Med J (Clin Res Ed); 1985 Oct; 291(6501):1047. PubMed ID: 3931783 [No Abstract] [Full Text] [Related]
4. Reduced incidence of hyperkalemia and azotemia in patients receiving sulindac compared with indomethacin. Nesher G; Zimran A; Hershko C Nephron; 1988; 48(4):291-5. PubMed ID: 3362274 [TBL] [Abstract][Full Text] [Related]
5. Indomethacin-induced azotaemia and hyperkalaemia: a case study. Nicholls MG; Espiner EA N Z Med J; 1981 Nov; 94(696):377-9. PubMed ID: 7033849 [TBL] [Abstract][Full Text] [Related]
6. Indomethacin-associated hyperkalemia in the elderly. Meier DE; Myers WM; Swenson R; Bennet WM J Am Geriatr Soc; 1983 Jun; 31(6):371-3. PubMed ID: 6853948 [No Abstract] [Full Text] [Related]
7. Coadministration of estradiol/drospirenone and indomethacin does not cause hyperkalemia in healthy postmenopausal women: a randomized open-label crossover study. Schütt B; Kunz M; Blode H J Clin Pharmacol; 2007 Jun; 47(6):774-81. PubMed ID: 17463217 [TBL] [Abstract][Full Text] [Related]
9. Indomethacin- and Moduretic--induced hyperkalemia. Mor R; Pitlik S; Rosenfeld JB Isr J Med Sci; 1983 Jun; 19(6):535-7. PubMed ID: 6862860 [TBL] [Abstract][Full Text] [Related]
10. Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring? Park IW; Sheen SS; Yoon D; Lee SH; Shin GT; Kim H; Park RW J Clin Pharm Ther; 2014 Feb; 39(1):61-8. PubMed ID: 24262001 [TBL] [Abstract][Full Text] [Related]
11. Indomethacin-induced hyperkalemia in three patients with gouty arthritis. Findling JW; Beckstrom D; Rawsthorne L; Kozin F; Itskovitz H JAMA; 1980 Sep; 244(10):1127-8. PubMed ID: 7411769 [TBL] [Abstract][Full Text] [Related]
12. Indomethacin-induced inhibition of prostaglandin with hyperkalemia. MacCarthy EP; Stokes GS Ann Intern Med; 1979 Sep; 91(3):500. PubMed ID: 475200 [No Abstract] [Full Text] [Related]
13. Coconut water-induced hyperkalaemia. Rees R; Barnett J; Marks D; George M Br J Hosp Med (Lond); 2012 Sep; 73(9):534. PubMed ID: 23124410 [No Abstract] [Full Text] [Related]
14. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients. Han SW; Won YW; Yi JH; Kim HJ Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126 [TBL] [Abstract][Full Text] [Related]
15. [Hyperkalemia without renal insufficiency associated with the taking of indomethacin]. Andrejak M; Fievet P; Hary L; Fournier A Therapie; 1985; 40(5):369-71. PubMed ID: 4095695 [No Abstract] [Full Text] [Related]
16. Hyperkalemia induced by indomethacin and naproxen and reversed by fludrocortisone. Mactier RA; Khanna R South Med J; 1988 Jun; 81(6):799-801. PubMed ID: 3375885 [TBL] [Abstract][Full Text] [Related]
17. Life-threatening hyperkalaemia during a haemodialysis session: an avoidable risk. Romagnoni M; Beccari M; Sorgato G Nephrol Dial Transplant; 1998 Oct; 13(10):2480-1. PubMed ID: 9794545 [No Abstract] [Full Text] [Related]
18. Hyperkalemia in the elderly. Walmsley RN; White GH; Cain M; McCarthy PJ; Booth J Clin Chem; 1984 Aug; 30(8):1409-12. PubMed ID: 6744599 [TBL] [Abstract][Full Text] [Related]
19. Indomethacin-induced hyperkalemia and renal failure in multiple myeloma. Paladini G; Tonazzi C Acta Haematol; 1982; 68(3):256-60. PubMed ID: 6814155 [TBL] [Abstract][Full Text] [Related]
20. Indomethacin-induced inhibition of prostaglandin with hyperkalemia. Beroniade V; Cornielle L; Haraoui B Ann Intern Med; 1979 Sep; 91(3):499-500. PubMed ID: 475198 [No Abstract] [Full Text] [Related] [Next] [New Search]